SHANDONG XINHUA PHARMACEUTICAL COMPANY LIMITED

Andere talen Shandong Xinhua Pharmaceutical Company Limited

Aandelen

719 CNE100000411

Beurs gesloten - Hong Kong S.E. Andere beurzen 10:08:49 06-05-2024			Variatie 5 dagen	Verschil t.o.v. 1 jan (%)
5,55 ^HKD	+2,02%		+1,83%	-3,98%

25/04	Shandong Xinhua Pharmaceutical Company Limited rapporteert resultaten voor het eerste kwartaal eindigend op 31 maart 2024	CI
11/04	Cefaclor-capsules van Xinhua Pharma-eenheid doorstaan reglementaire evaluatie	MT

Andere talen

Krijg toegang tot al het nieuws over alle bedrijven: mis nooit meer een winstgevende beleggingskans!

Gratis inschrijven

Shandong Xinhua Pharmaceutical Company Limited Reports Earnings Results for the First Quarter Ended March 31, 2024	25/04
Xinhua Pharma Unit's Cefaclor Capsules Passes Regulatory Evaluation	11/04
Shandong Xinhua Pharmaceutical Company Limited Receives Notification of Approval of Supplementary Drug Application	08/04
Shandong Xinhua Pharmaceutical Posts Higher 2023 Profit	29/03
Shandong Xinhua Pharmaceutical Proposes New Auditor	29/03
Shandong Xinhua Pharmaceutical Company Limited Proposes Final Dividend for the Year Ended 31 December 2023	28/03
Shandong Xinhua Pharmaceutical Company Limited Reports Earnings Results for the Full Year Ended December 31, 2023	28/03
Xinhua Pharma's Ibuprofen Gets Registration Approval in China	13/03
Shandong Xinhua Pharmaceutical Company Limited Receives Notification of Approval of Application for Marketing of Active Pharmaceutical Ingredient	28/02
Shandong Xinhua Pharmaceutical Company Limited Announces on Memantine Hydrochloride Tablets Obtaining the Drug Registration Certificate	19/01
Shandong Xinhua Pharmaceutical Company Limited Announces Executive Changes	25/12
Shandong Xinhua Pharmaceutical Gets Certificate for Registration of Levamlodiping Besylate Tablets	13/12
Shandong Xinhua Pharmaceutical Company Limited Receives Drug Registration Certificate of levamlodiping besylate tablets (2.5mg)	13/12
Respiratory Drug by Xinhua Pharmaceutical Unit Passes Regulatory Evaluation for Generic Drugs in China	04/12
Xinhua Pharmaceutical's Nine-Month Profit Jumps 34%	30-10-23
Shandong Xinhua Pharmaceutical Company Limited Reports Earnings Results for the Nine Months Ended September 30, 2023	27-10-23
Shandong Xinhua Pharmaceutical’s AntiCoagulant Tablets Get Drug Registration Certificate	18-10-23
China Grants Marketing Approval for Shandong Xinhua Pharmaceutical's Uric Acid Medication; Shares Rise 4%	11-10-23
Shandong Xinhua Pharmaceutical Company Limited Announces Approval of Marketing Application for Chemical Raw Material Drugs for Drugsof Febuxostat	10-10-23
Xinhua Pharmaceutical Unit's Clarithromycin Granules Passes Regulatory Evaluation	20-09-23

Geen resultaten voor deze zoekopdracht

Al het nieuws Aanbevelingen van analisten Belangrijkste gebeurtenissen Insiders Transcripties Persberichten Officiële publicaties Andere talen Ideeën voor de handel MarketScreener-artikels MarketScreener-analyses

Andere talen Shandong Xinhua Pharmaceutical Company Limited

Aandelen

719

CNE100000411

Andere talen

Filters